Meta-Analysis of the Prognostic and Clinical Value of Tumor-Associated Macrophages in Hepatocellular Carcinoma

Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value

(2017) Chun-Xia Ren et al.   ONCOLOGY REPORTS

Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide

(2017) Pablo Scodeller et al.   Scientific Reports

Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment

(2016) Qods Lahmar et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis

(2016) Qiang-Bo Zhang et al.   BMC CANCER

miR-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis

(2016) Shao-Lai Zhou et al.   HEPATOLOGY

Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection

(2016) Qing-Hua Shu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma

(2016) Yi Zhang et al.   JOURNAL OF PATHOLOGY

Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma

(2016) Hiroshi Kono et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection

(2016) Zhi-Qiang Hu et al.   Oncotarget

Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy

(2015) R. Hughes et al.   CANCER RESEARCH

Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages

(2015) Wenjiang Yan et al.   GUT

Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma

(2015) Oscar W.H. Yeung et al.   JOURNAL OF HEPATOLOGY

Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages

(2015) Leslie Chávez-Galán et al.   Frontiers in Immunology

CNS macrophages and peripheral myeloid cells in brain tumours

(2014) Rainer Glass et al.   ACTA NEUROPATHOLOGICA

The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2

(2013) James Lee et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma

(2013) Georg C Hutterer et al.   HISTOPATHOLOGY

The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma

(2013) Ling-Qun Kong et al.   PLoS One

Nanobody-Based Targeting of the Macrophage Mannose Receptor for EffectiveIn VivoImaging of Tumor-Associated Macrophages

(2012) Kiavash Movahedi et al.   CANCER RESEARCH

Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head

(2012) Kiyoshi Yoshikawa et al.   CANCER SCIENCE

Engagement of the Mannose Receptor by Tumoral Mucins Activates an Immune Suppressive Phenotype in Human Tumor-Associated Macrophages

(2011) P. Allavena et al.   Clinical & Developmental Immunology

Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy

(2011) David G. DeNardo et al.   Cancer Discovery

The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time

(2010) Junliang Ma et al.   BMC CANCER

High Expression of Macrophage Colony-Stimulating Factor-1 Receptor in Peritumoral Liver Tissue Is Associated with Poor Outcome in Hepatocellular Carcinoma After Curative Resection

(2010) J.-B. Jia et al.   ONCOLOGIST

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1

(2009) Dong-Ming Kuang et al.   JOURNAL OF EXPERIMENTAL MEDICINE

High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection

(2008) Tong Ding et al.   HUMAN PATHOLOGY

Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection

(2008) Yi-Wei Li et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma

(2008) Xiao-Dong Zhu et al.   JOURNAL OF CLINICAL ONCOLOGY